Outcome and Complications of Combined Modified Deep Sclerectomy and Trabeculectomy for Surgical Management of Glaucoma: A Pilot Study.

combined modified deep sclerectomy and trabeculectomy outcome and complications

Journal

Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512

Informations de publication

Date de publication:
2020
Historique:
received: 06 01 2020
accepted: 11 02 2020
entrez: 27 3 2020
pubmed: 27 3 2020
medline: 27 3 2020
Statut: epublish

Résumé

To report the outcome and complications of a combined surgical technique of modified deep sclerectomy and trabeculectomy (mDST) for glaucoma. Retrospective study of 44 eyes of 43 patients with open and closed angle glaucoma who underwent mDST. Outcome measures were: Surgical Success with 3 criteria - (i) criterion 1 = intraocular pressure (IOP) ≤21 mmHg or reduced by ≥20% of pre-operative IOP or IOP ≥6 mmHg on 2 consecutive time points after 3 months; (ii) criterion 2 = IOP ≤18 mmHg or reduced by ≥30% of pre-operative IOP or IOP ≥6 mmHg on 2 consecutive time points after 3 months and (iii) criterion 3 = IOP ≤15 mmHg or reduced by ≥40% of pre-operative IOP or IOP ≥6 mmHg on 2 consecutive time points after 3 months; IOP Reduction; Use of Anti-glaucoma Medication; Complications; Visual Acuity and Postoperative Interventions. Median follow-up was 40 months (range 24-77 months). At the final follow-up visit, the mean postoperative IOP was 11.5 ± 4.7 mmHg (p<0.0001). Mean number of anti-glaucoma medications decreased from 2.45 ± 1.21 to 0.54 ± 0.95 (p<0.0001). Surgical success in terms of IOP reduction was 50%; 43.2%; 36.4% for the 3 criteria respectively (complete success) and 70.5%; 56.8%; 47.7% for the 3 criteria respectively (qualified success). The complications noted were shallow/flat anterior chamber in 2 (4.54%), hyphema & bleb leak in 3 (6.81%), aqueous misdirection in 1 (2.27%), hypotonic maculopathy in 2 (4.45%) and hypotony requiring intervention in 6 (13.63%) eyes. Combined mDST was found to be an effective surgical procedure in reducing IOP. It was associated with complications commonly encountered in glaucoma filtering surgery. The use of intra-scleral space maintainer may help lower the risk of flat or shallow anterior chamber during the early postoperative period.

Identifiants

pubmed: 32210532
doi: 10.2147/OPTH.S244945
pii: 244945
pmc: PMC7075434
doi:

Types de publication

Journal Article

Langues

eng

Pagination

795-803

Informations de copyright

© 2020 Sangtam et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

J Glaucoma. 2009 Feb;18(2):132-9
pubmed: 19225350
J Glaucoma. 2002 Jun;11(3):214-20
pubmed: 12140398
Am J Ophthalmol. 2009 Nov;148(5):670-84
pubmed: 19674729
JAMA Ophthalmol. 2013 Dec;131(12):1573-82
pubmed: 24158640
Ophthalmology. 1998 Apr;105(4):746-50
pubmed: 9544651
J Glaucoma. 2004 Dec;13(6):500-6
pubmed: 15534477
Ophthalmology. 2007 Dec;114(12):2265-70
pubmed: 17466376
Eur J Ophthalmol. 2008 Sep-Oct;18(5):751-7
pubmed: 18850554
Ophthalmology. 2000 Sep;107(9):1671-4
pubmed: 10964827
Am J Ophthalmol. 1996 Apr;121(4):349-66
pubmed: 8604728
Eye (Lond). 2001 Apr;15(Pt 2):197-201
pubmed: 11339590
Graefes Arch Clin Exp Ophthalmol. 2002 Nov;240(11):918-23
pubmed: 12486514
Ophthalmology. 2000 Jun;107(6):1184-90
pubmed: 10857841
Arch Ophthalmol. 2002 Mar;120(3):297-300
pubmed: 11879132
Am J Ophthalmol. 2009 Nov;148(5):685-695.e1
pubmed: 19596220
Am J Ophthalmol. 1968 Oct;66(4):673-9
pubmed: 4891876
J Cataract Refract Surg. 1999 Mar;25(3):323-31
pubmed: 10079436
Am J Ophthalmol. 2012 May;153(5):789-803.e2
pubmed: 22245458
J Ocul Pharmacol. 1990 Fall;6(3):175-82
pubmed: 2127056
Int Ophthalmol. 2010 Jun;30(3):271-7
pubmed: 19960232
Am J Ophthalmol. 2002 Oct;134(4):481-98
pubmed: 12383805

Auteurs

Tiakumzuk Sangtam (T)

Glaucoma Center Montchoisi Clinic, Lausanne, Switzerland.
Department of Ophthalmology & Visual Sciences, Khoo Teck Puat Hospital, Singapore.

Sylvain Roy (S)

Glaucoma Center Montchoisi Clinic, Lausanne, Switzerland.
Laboratory of Hemodynamics and Cardiovascular Technology, Swiss Federal Institute of Technology, Lausanne, Switzerland.

André Mermoud (A)

Glaucoma Center Montchoisi Clinic, Lausanne, Switzerland.

Classifications MeSH